A. Ribas
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 26
- Cancer Immunotherapy and Biomarkers 16
- CAR-T cell therapy research 13
- Cutaneous Melanoma Detection and Management 8
-
- Melanoma and MAPK Pathways 17
- Co-authors
- Richard Kefford (5 shared papers)Jesús Gómez-Navarro (3 shared papers)Axel Hauschild (5 shared papers)Claus Garbe (5 shared papers)J.B.A.G. Haanen (3 shared papers)Dmitri Pavlov (2 shared papers)C.J.A. Punt (1 shared paper)Igor Puzanov (8 shared papers)
- Journals
- Annals of Oncology (13 papers)Journal of Clinical Oncology (10 papers)European Journal of Cancer (5 papers)Melanoma Research (2 papers)Blood (1 paper)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
A. Ribas
41 papers receiving 595 citations
Peers
Comparison fields: 5 of 57
- Oncology 407
- Immunology 169
- Molecular Biology 265
- Cancer Research 33
- Hematology 25
Countries citing papers authored by A. Ribas
This map shows the geographic impact of A. Ribas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ribas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ribas more than expected).
Fields of papers citing papers by A. Ribas
This network shows the impact of papers produced by A. Ribas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ribas. The network helps show where A. Ribas may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Ribas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 135 | |
| 2 | 2011 | 111 | |
| 3 | Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosis. | 1996 | 41 |
| 4 | 2021 | 38 | |
| 5 | 2010 | 30 | |
| 6 | 2002 | 28 | |
| 7 | What is the role of recombinant colony stimulating factors in bone marrow transplantation? | 1990 | 23 |
| 8 | 2010 | 21 | |
| 9 | 2009 | 21 | |
| 10 | 2014 | 20 | |
| 11 | 2004 | 18 | |
| 12 | Phase III randomized, open-label, multicenter trial (BRIM3) comparing BRAF inhibitor vemurafenib with dacarbazine (DTIC) in patients with V600E BRAF-mutated melanoma | 2011 | 13 |
| 13 | 2017 | 13 | |
| 14 | 2010 | 12 | |
| 15 | 2015 | 11 | |
| 16 | Pembrolizumab plus ipilimumab for advanced melanoma : results of the keynote-029 expansion cohort | 2016 | 8 |
| 17 | 2015 | 7 | |
| 18 | 1997 | 6 | |
| 19 | 2018 | 6 | |
| 20 | 2021 | 4 |
About A. Ribas
A. Ribas is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Immunology and Computational Theory and Mathematics, having authored 41 papers that have together received 615 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), CAR-T cell therapy research (13 papers), Cutaneous Melanoma Detection and Management (8 papers), Synthesis of Tetrazole Derivatives (6 papers), Immunotherapy and Immune Responses (6 papers), Computational Drug Discovery Methods (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (407 citations), Immunology (169 citations), Molecular Biology (265 citations), Cancer Research (33 citations) and Hematology (25 citations). A. Ribas has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Richard Kefford, Jesús Gómez-Navarro, Axel Hauschild, Claus Garbe, J.B.A.G. Haanen, Dmitri Pavlov, C.J.A. Punt, Igor Puzanov, Grant A. McArthur and Keith T. Flaherty. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, Melanoma Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.